VRTX · Healthcare
Vertex Pharmaceuticals Inc
34/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
45
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$132.8B
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqGS
About VERTEX PHARMACEUTICALS INC
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of…
Who's behind the signal
Every informed buyer we can see on VRTX, across all three feeds.
Hedge funds · 8
D.E. Shaw & Co
New position
Tweedy Browne
Increased +3%
AQR Capital Management
Increased +19%
Citadel Advisors
Decreased −21%
Baillie Gifford & Co
Unchanged
Gotham Asset Mgmt (Greenblatt)
Decreased −3%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 9 on record
Disclosures from 2015-05-13 to 2022-03-29
The newest disclosure we hold for this stock is 2022-03-29.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-03-29 | William R. Keating · D-MA | House | Bought | $1,001 - $15,000 |
| 2021-01-28 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2020-12-18 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant · R-TX | House | Sold | $1,001 - $15,000 |
| 2019-06-24 | Donna E. Shalala · D-FL | House | Sold | $1,001 - $15,000 |
| 2019-04-18 | Donna E. Shalala · D-FL | House | Bought | $1,001 - $15,000 |
| 2019-02-04 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2018-03-09 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2015-05-13 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
VERTEX PHARMACEUTICALS INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
1
New positions
2
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
NEW
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.2×
% of portfolio
1.4%
Position change
+3%
1.4% of Tweedy Browne's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+19%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−21%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.4×
% of portfolio
0.1%
Position change
—
0.1% of Baillie Gifford & Co's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
−3%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−51%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−92%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to VERTEX PHARMACEUTICALS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell VERTEX PHARMACEUTICALS INC or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订